U.S. Physical Therapy November 5, 2026 Earnings Call 10:30 am ET Operator

U.S. Physical Therapy reported Q3 revenue growth of 13% to $223M, with EBITDA up 16% to $28M. The company reaffirmed its full-year EBITDA guidance of $102M-$106M. Growth was driven by increased physical therapy visits and hospital affiliations, while higher employee health benefit costs impacted margins.

U.S. Physical Therapy (USPH) reported Q3 earnings, with adjusted physical therapy margins rising 60 basis points YoY to 19%, despite higher medical costs. The company plans acquisitions and clinic expansions. Industrial injury prevention revenue grew 14% to $33M. GAAP net income fell to $11M from $13M YoY. USPH ended Q3 with $38M in cash and $247M in borrowings.

U S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Results of Operations and Financial Condition. CONTACT: U.S. Physical Therapy, Inc. Nchacha Etta, Chief Financial Officer email: netta@usph.com (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 USPH Reports Third Quarter 2026 Results, Record High Visits and Revenue Per Visit Houston, TX, November 4, 2026 – U.S. Phy

US Physical Therapy Inc (USPH) reported Q3 2026 revenue growth of 13% to $223M, driven by record patient visits and hospital affiliations. Net rate per visit hit $112, and EBITDA grew over 16%. The company reaffirmed full-year EBITDA guidance of $102M-$106M but faced higher self-insured group health costs and increased interest expenses. Management expects continued growth from hospital partnerships and cautious about medical cost trends.

U.S. Physical Therapy reported Q3 2026 revenue of $223M, up 13% YoY, with net income of $6M. Patient visits rose 8% to 1.7M, and revenue per visit hit $111. Adjusted EBITDA increased to $24M. The company declared a $0.46 dividend and reaffirmed its 2026 adjusted EBITDA guidance.

US Physical Therapy (USPH) appointed Nchacha Etta as CFO, effective September 1. Etta previously held CFO roles at Omnicell (OMCL) and Johnson & Johnson Vision. USPH reported Q2 2026 revenue of $214.1M, up 8.5%, but net income fell to $9.9M from $12.4M. The company reaffirmed full-year adjusted EBITDA guidance of $102M-$106M.